ROCO
6130
Market cap33mUSD
Oct 08, Last price
23.00TWD
1D
0.66%
1Q
-12.21%
Jan 2017
-12.41%
IPO
-45.50%
Name
Singbao International Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Based in Taipei, Taiwan, and established in 1994, Shangya Technology Co., Ltd. is a multifaceted enterprise with operations spanning several key sectors. The company primarily engages in the wholesale distribution of a diverse range of products within Taiwan, including traditional Chinese medicines, Western pharmaceuticals, medical equipment, weight-loss solutions, and beauty supplies. Beyond its distribution activities, Shangya Technology is also deeply involved in the design, development, manufacturing, and marketing of advanced integrated circuits (ICs). These include chips for wireless communication, satellite navigation systems, and various portable electronic devices. Additionally, the company extends its reach into the service industry, managing a network of beauty salons and providing a variety of other related offerings. Notably, the company underwent a name change in July 2023, adopting its current designation of Shangya Technology Co., Ltd., having previously operated as Singbao International Co. Ltd.
Key people
Qianqi Huang
Chairman of the Board · since 2025
Youtan Cai
Chief Executive Officer · since 2025
Xiaoling Huang
Chief Financial Officer · since 2025
Zhonghe Cai
General Manager · since 2025
Xiang'en Wu
Chief Information Security Officer · since 2023
Yinggui Zeng
Head of Finance, Head of Accounting, Corporate Governance Officer · since 2025
Qingwen Cao
Director · since 2025
Tengting Huang
Director · since 2021
Zhizhen Lin
Director · since 2025
Yucheng Su
Director · since 2018
Songyuan Wu
Director · since 2025
Youquan Zeng
Director · since 2021
Boyu Chen
Independent Director · since 2025
Independent Director · since 2020
Huangqing Wu
Independent Director · since 2017
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||